Sten Nilsson

MD, PhD/Board Member

Sten Nilsson, MD, PhD, is a professor emeritus in oncology at Karolinska Institutet, Solna. He is a specialist in oncology and in nuclear medicine. Sten Nilsson was head of the urology cancer group at Uppsala University Hospital and at Radiumhemmet, Karolinska University Hospital, for several years and for the Oncology Clinic, Radiumhemmet, Karolinska University Hospital, from 2006 to 2008. Sten Nilsson is leading his prostate cancer research program at CancerCentrum Karolinska (CCK) and BioClinicum, Karolinska Institutet, focusing on the development of novel cancer medicines. He has previously been president of the Swedish Society of Oncology, the Swedish Association of Urological Oncology, and the Swedish Association of Nuclear Medicine. Sten Nilsson is one of the founders and main shareholders of Dextech Medical and the chairman of the Rhenman & Partners Scientific Advisory Board.

Position: Board Member

Elected: January 2024

Year of birth: 1948

Holdings: 3 101 shares*

Independent in relation to the company and its management: Yes

Independent in relation to larger shareholders: Yes

*Own or related natural or legal person holding shares and other financial instruments in the company. Holdings as of June 30, 2024.